NIPBL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.922100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.632400E-02
Normal-vs-Stage2
4.024100E-02
Normal-vs-Stage3
1.459780E-02
Normal-vs-Stage4
1.887760E-01
Stage1-vs-Stage2
5.329800E-01
Stage1-vs-Stage3
2.768300E-02
Stage1-vs-Stage4
7.598600E-01
Stage2-vs-Stage3
1.214230E-01
Stage2-vs-Stage4
8.476600E-01
Stage3-vs-Stage4
2.006200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.027700E-02
Normal-vs-AfricanAmerican
4.513200E-01
Normal-vs-Asian
1.327230E-01
Caucasian-vs-AfricanAmerican
2.423600E-01
Caucasian-vs-Asian
7.995600E-01
AfricanAmerican-vs-Asian
5.399000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.701500E-02
Normal-vs-Female
5.133700E-02
Male-vs-Female
8.384400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.245800E-01
Normal-vs-Age(41-60Yrs)
7.825600E-02
Normal-vs-Age(61-80Yrs)
3.452400E-02
Normal-vs-Age(81-100Yrs)
9.635100E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.751800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.602000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.486240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.071600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.333700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.026800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.375300E-03
Normal-vs-Daily Drinker
5.168500E-02
Normal-vs-Weekly Drinker
6.368100E-02
Normal-vs-Occasional Drinker
4.972200E-02
Normal-vs-Social Drinker
7.303800E-02
Non Drinker-vs-Daily Drinker
5.719400E-01
Non Drinker-vs-Weekly Drinker
4.415400E-01
Non Drinker-vs-Occasional Drinker
6.113900E-02
Non Drinker-vs-Social Drinker
1.138380E-01
Daily Drinker-vs-Weekly Drinker
8.339600E-01
Daily Drinker-vs-Occasional Drinker
2.942200E-01
Daily Drinker-vs-Social Drinker
3.944800E-01
Weekly Drinker-vs-Occasional Drinker
4.415600E-01
Weekly Drinker-vs-Social Drinker
5.491000E-01
Occasional Drinker-vs-Social Drinker
9.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.209000E-01
Normal-vs-Grade 2
8.691800E-01
Normal-vs-Grade 3
8.292600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.281400E-01
Grade 1-vs-Grade 3
8.863800E-01
Grade 1-vs-Grade 4
8.209000E-01
Grade 2-vs-Grade 3
2.426600E-01
Grade 2-vs-Grade 4
8.691800E-01
Grade 3-vs-Grade 4
8.292600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.936400E-03
Normal-vs-NonDiabetic
3.814500E-02
Diabetic-vs-NonDiabetic
2.027600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.261700E-02
Normal-vs-NoPancreatitis
2.772000E-02
Pancreatitis-vs-NoPancreatitis
7.263200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.093800E-02
Normal-vs-N1
4.537700E-02
N0-vs-N1
8.686400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.346610E-01
Normal-vs-TP53-NonMutant
2.067200E-01
TP53-Mutant-vs-TP53-NonMutant
9.322000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
